Biotech news
Americas
Inter-partes reviews (IPRs) can be a powerful weapon against patents listed in the Orange Book. However, IPR practice favours a petitioner who has carefully thought about the issues and crafted the best strategy, says Mark Remus of Brinks Gilson & Lione. 4 August 2016
Americas
Pfizer has acquired Bamboo Therapeutics, a biotechnology company based in North Carolina. 3 August 2016
Americas
The US Court of Appeals for the Federal Circuit yesterday affirmed a district court’s order to deny arbitration in a patent infringement case between Illumina and Ariosa Diagnostics. 27 July 2016
Americas
Law firm Cooley announced yesterday that it is expanding its patent counselling and prosecution practice with the addition of Mika Reiner Mayer’s team from law firm Morrison Foerster. 26 July 2016
Biotech
In order to be well prepared before a generic or biosimilar marketing authorisation is approved, drugs companies in the EU may consider monitoring pending applications, says Ruth Franken of Hogan Lovells. 26 July 2016
Americas
Technology company Philips has bought Wellcentive, a US-based company that provides health management solutions. 25 July 2016
Pharma
Mayer Brown announced today that Genevieve Michaux has joined the firm’s government & global trade practice as partner in Brussels. 20 July 2016
Asia
Indonesia has ordered the immediate revamping of the Food and Drug Administration following the successful police investigation uncovering the selling, importing and utilisation of a fake child vaccine. 19 July 2016
Africa
Everyone benefits from an efficiently run clinical drug study, including sponsors, contract research organisations, the investigator sites where patients are treated and observed, and most of all, patients, says Charlie Nicholson of Premier Research. 19 July 2016
Americas
Illumina has reached a settlement with Enzo Life Sciences, bringing an end to allegations that it infringed a DNA detection patent. 14 July 2016